Actively Recruiting
Circulating circRNA in Acute Ischemic Stroke
Led by The Affiliated Hospital of Xuzhou Medical University · Updated on 2024-08-06
500
Participants Needed
1
Research Sites
212 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.
CONDITIONS
Official Title
Circulating circRNA in Acute Ischemic Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Confirmed acute ischemic stroke by a diffusion-weighted imaging-position lesion on magnetic resonance imaging (MRI) and a new lesion on a brain computed tomography (CT) scan
- Within 72 hours of symptom onset
- Good performance status
- Signed an approved informed consents
You will not qualify if you...
- History of hemorrhagic infarction
- Chronic kidney or liver diseases
- Peripheral arterial occlusive disease
- Active malignant disease
- Inflammatory or infectious diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurology
Xuzhou, Jiangsu, China
Actively Recruiting
Research Team
X
Xingzhi Wang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here